HealthLynked Corp. (HLYK) CEO Provides $1 Million Financing

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
275
HealthLynked Corp. (HLYK) CEO Provides $1 Million Financing to Speed Company’s Continued Success in Revolutionizing Healthcare Industry

- HealthLynked CEO Dr. Michael Dent recently provided $1 million in financing to the company, expected to accelerate its growth and expand its offerings
- Under Dr. Dent’s leadership, the company has developed an expansive array of products and services, including a comprehensive healthcare platform that connects patients, healthcare providers, and medical facilities in a secure, more efficient and cost-effective manner
- The company’s services include online medical records storage, online appointment scheduling for doctors nationwide, telemedicine, patient engagement tools, an e-commerce platform for over 15,000 name-brand medical supplies, concierge patient support, nurse chat, a reward points program, and co-management of family members’ healthcare
- According to Dr. Dent, the financing underscores his belief in the transformative power of HealthLynked’s services and its mission to create a more efficient healthcare system for the benefit of everyone

HealthLynked (OTCQB: HLYK), a Naples, Florida-based leader in personalized healthcare and patient-centric services, leverages technology to provide innovative solutions to healthcare problems, ensuring more efficient, accessible, and personalized healthcare for all. At the heart of the company’s mission is an unwavering determination to transform healthcare on a global scale with the aim of improving the medical practice efficiency and, as a result, increasing the reach of high-quality healthcare services and ensuring more accurate medical diagnosis (https://nnw.fm/TyUx7 ).

“The current healthcare system is fragmented and inefficient, often leaving patients frustrated and underserved. At HealthLynked, we are pioneering a new era of healthcare that prioritizes seamless connectivity, personalized care, and data-driven insights,” explained Dr. Michael Dent, CEO of HealthLynked, in a June 5 news release.

The company’s founder and a visionary in the healthcare industry, Dr. Dent has led HealthLynked in developing an expansive array of innovative products and services. Among them is the company’s comprehensive healthcare platform, the HealthLynked Network System, that securely, efficiently, and cost-effectively connects patients, healthcare providers, and medical facilities.

The platform supports a range of services, including online medical records storage, online appointment scheduling for doctors nationwide, telemedicine, and patient engagement tools. According to the company, the healthcare platform aims to improve patient outcomes and increase efficiency throughout the healthcare system (https://nnw.fm/AcTWV ). In addition to its platform’s offerings, HealthLynked offers additional services: an e-commerce platform for over 15,000 name-brand medical supplies, concierge patient support, nurse chat, a reward points program, and co-management of family members’ healthcare.

To ensure that more patients and healthcare providers can benefit from these innovative solutions and services, HealthLynked recently received $1 million in financing from its CEO Dr. Dent (https://nnw.fm/7B67J ). According to the June 5 announcement, the financing is expected to provide HealthLynked with an additional capital runway for accelerating its growth and expanding its offerings further.

“Providing funding to HealthLynked is a testament to my belief in the transformative power of our services and our mission to create a more efficient healthcare system for the benefit of everyone,” commented Dr. Dent. “This financing is not just about financial growth; it’s about leading the way to a more efficient healthcare system of the future, protecting our shareholders’ interests, and assisting our continued success in revolutionizing the healthcare industry.”

Dave Rosal, CFO of HealthLynked, believes this funding will allow the company to “enhance our service offerings and reach more patients and healthcare providers, ultimately driving shareholder value and solidifying our market position in the market.” He also notes that the financing demonstrates Dr. Dent’s commitment to the company, which, in turn, spotlights the strength of its business model and confidence in its strategic direction.

HealthLynked believes this new financing sets it on a path for even greater success and impact in the healthcare sector. It also boosts the company’s efforts to continue to innovate and expand its reach, providing vital healthcare solutions that cater to the needs of patients and healthcare providers.

For more information, visit the company’s website at www.HealthLynked.com.

NOTE TO INVESTORS: The latest news and updates relating to HLYK are available in the company’s newsroom at https://nnw.fm/HLYK

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

Healthlynked Corp (HLYK) Stock Research Links

HLYK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 188

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 375

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 178

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 92

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 169

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Oasis Management Proposes Governance Change for Kobayashi Pharma

Updated Category News Views 243

Oasis Management Advocates for Enhanced Governance at Kobayashi Pharma Oasis Management Company Ltd. (“Oasis”) has emerged as a significant voice among shareholders of Kobayashi Pharmaceutical Co., Ltd. (4967 JT). Holding over 7.5% of the company, Oasis is actively pushing for essential changes in leadership and independent oversight to address pressing governance...

Continue Reading
Synopsys Faces Legal Challenges Amid Stockholder Concerns

Updated Category News Views 235

Understanding the Recent Class Action Lawsuit Against Synopsys Recently, concerns have emerged regarding Synopsys, Inc. as a class action lawsuit was filed alleging serious misrepresentations concerning the company’s financial health. Investors who have been affected are encouraged to seek guidance to explore their legal rights and options that may arise from this...

Continue Reading
Cumulus Media's Engaging Coverage of 2025 NCAA Basketball Events

Updated Category News Views 228

Thrilling NCAA Basketball Coverage by Cumulus Media Cumulus Media’s Westwood One is gearing up for an exciting audio experience during the 2025 NCAA Men’s and Women’s Basketball tournaments. With the largest radio network in the country, Westwood One will deliver comprehensive coverage that connects die-hard sports fans across a plethora of platforms. Connecting...

Continue Reading
ByteDance's Ambitious AI Chip Investment Plans for 2025

Updated Category News Views 1644

ByteDance's Strategic Investment in AI Technology ByteDance, the renowned owner of TikTok, is making significant strides in artificial intelligence by planning to invest more than $12 billion on AI infrastructure in the upcoming years. This ambitious investment highlights the company's commitment to harnessing cutting-edge technology for growth. According to reports, the...

Continue Reading
Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit

Updated Category News Views 130

Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit The law firm Robbins Geller Rudman & Dowd LLP is calling for investors of ModivCare, Inc. (NASDAQ: MODV) who have experienced significant financial losses to take action. Understanding the Class Action Lawsuit The upcoming class action lawsuit, titled Kalera v. ModivCare, Inc., brings serious allegations...

Continue Reading